Trinity Biotech plc (NASDAQ:TRIB) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Trinity Biotech plc have been assigned a consensus rating of "Hold" from the six research firms that are currently covering the firm, reports . One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company.

from Biotech News